Annals
Established in 1927 by the American College of Physicians
:
Advanced search
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Albert, M. R.
space
  arrow  Breman, J. G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

HISTORY OF MEDICINE

Smallpox Manifestations and Survival during the Boston Epidemic of 1901 to 1903

right arrow Michael R. Albert, MD; Kristen G. Ostheimer, MA; David J. Liewehr, MS; Seth M. Steinberg, PhD; and Joel G. Breman, MD, DTPH

17 December 2002 | Volume 137 Issue 12 | Pages 993-1000

Clinical records of 243 patients with smallpox consecutively admitted to the Southampton Street smallpox hospital in Boston, Massachusetts, during the 1901–1903 epidemic were reviewed. Smallpox was divided into five categories of varying severity; 47% of patients had varioloid, a relatively mild form of the disease usually occurring in previously vaccinated individuals with incomplete immunity. Survival information is available for 206 patients, of whom 36 (17.5%) died. Vaccination status, disease severity, and age were associated with survival, whereas sex, birthplace, and race were not. While full recovery often took weeks, most deaths occurred 7 to 14 days after the onset of symptoms, and all deaths occurred within 18 days of symptom onset. Smallpox was eradicated worldwide in 1977, but knowledge of the disease is essential because its cause, variola virus, is considered a potential biological weapon.

Author and Article Information
space

From the National Cancer Institute and National Institutes of Health, Bethesda, Maryland; and Yale–New Haven Hospital, New Haven, Connecticut.

Acknowledgments: The authors thank Pierce Gardner and Mark Miller of the Fogarty International Center, National Institutes of Health; Stephen Katz of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health; and D.A. Henderson of Johns Hopkins University for their critical reading of this manuscript.

Requests for Single Reprints: Joel G. Breman, MD, DTPH, Fogarty International Center, National Institutes of Health, 16 Center Drive, MSC 6705, Building 16, Room 214, Bethesda, MD 20892; e-mail, jbreman{at}nih.gov.

Current Author Addresses: Dr. Albert: Rhode Island Hospital, Department of Dermatology, 593 Eddy Street, APC 10, Providence, RI 02903.

Ms. Ostheimer: Yale–New Haven Hospital, 20 York Street, Room 1096 CB, New Haven, CT 06504.

Mr. Liewehr and Dr. Steinberg: National Cancer Institute, Center for Cancer Research, Biostatistics and Data Management Section, 6116 Executive Boulevard, Room 702, MSC 8325, Bethesda, MD 20892.

Dr. Breman: Fogarty International Center, National Institutes of Health, 16 Center Drive, MSC 6705, Building 16, Room 214, Bethesda, MD 20892.




This article has been cited by other articles:


Home page
The Annals of PharmacotherapyHome page
R. Guharoy, R. Panzik, J. A Noviasky, E. P Krenzelok, and D. C Blair
Smallpox: Clinical Features, Prevention, and Management
Ann. Pharmacother., March 1, 2004; 38(3): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, February 15, 2003; 326(7385): 404 - 404.
[Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2002 by the American College of Physicians.